Cargando…
Are current development programs realising the full potential of new agents?
Autor principal: | Lønning, Per Eystein |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005743/ https://www.ncbi.nlm.nih.gov/pubmed/21172086 http://dx.doi.org/10.1186/bcr2752 |
Ejemplares similares
-
Are current drug development programmes realising the full potential of new agents? The scenario
por: Johnston, Stephen RD
Publicado: (2009) -
Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors
por: Gutteridge, Eleanor, et al.
Publicado: (2009) -
Introduction: are current drug development programmes realising the full potential of new agents?
por: Johnston, Stephen RD, et al.
Publicado: (2010) -
Strength and weakness of phase I to IV trials, with an emphasis on translational aspects
por: Lønning, Per Eystein
Publicado: (2008) -
Tailored targeted therapy for all: a realistic and worthwhile objective?
por: Lønning, Per Eystein
Publicado: (2009)